Sigma Healthcare (ASX:SIG) FFO


ASX:SIG Sigma Healthcare Ltd ASX:SIG
59 GF Score
Price A$2.77
GF Value A$0.37
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Sigma Healthcare FFO?

FFO (Funds from operations) only applies to REITs.

ASX:SIG
59GF Score
Sigma Healthcare Ltd ASX:SIG
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sigma Healthcare (ASX:SIG) Overvalued in 2026?

Based on GuruFocus' analysis, Sigma Healthcare stock appears to be overvalued. The current stock price of A$2.77 is trading 648.6% above its estimated GF Value™ of A$0.37. GuruFocus considers Sigma Healthcare to be Significantly Overvalued.

Key valuation signals for ASX:SIG:

  • FFO:
  • GF Value™: A$0.37 vs. price of A$2.77 (648.6% above fair value)
  • GF Score™: 59/100 with 8 warning signs

No single metric tells the full story. See the ASX:SIG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sigma Healthcare Business Description

Address 6 Albert Street, Preston, VIC, AUS, 3072
Sigma Healthcare is Australia's largest retail pharmacy franchisor, most notably owning the Chemist Warehouse brand, which it merged with in 2025. Sigma is also Australia's largest full-line wholesaler to franchised and independent pharmacies and distributes a broad range of pharmacy products, including prescription medicines, over-the-counter products, and front of store, or FOS, products, at low prices. The group also operates in New Zealand, Ireland, China, and Dubai, has a growing private label range, and offers third-party logistics services.
59GF Score

Get the complete analysis for ASX:SIG

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$2.77
Price
A$0.37
GF Value